Bucher C, Jordan P, Nickeleit V, Torhorst J, Mihatsch M J
Institute for Pathology, University of Basle, Switzerland.
Clin Nephrol. 1999 Feb;51(2):67-72.
Nonsteroidal anti-inflammatory drugs (NSAID) e.g. aspirin, indomethacin are reported in epidemiological and experimental studies to reduce the risk for colo-rectal cancer and potentially other malignant tumors.
We examined the effect of NSAIDs on tumor prevalence in abusers of mixed analgesics containing aspirin, phenacetine, caffeine or codein. 618 analgesic abusers who were autopsied between 1968-1983 were compared with a control group without evidence of analgesic abuse matched for sex, age and year autopsy was performed.
Abusers were found to have an overall risk of 0.40 fold of having developed a malignancy as compared with the controls. Excluding patients with urinary tract tumors which are increased in analgesic abusers the risk was further decreased to 0.28. No statistically significant effect was found for patients with prostate cancer. The results encourage prospective control studies in high risk patients.
在流行病学和实验研究中,据报道非甾体抗炎药(NSAID),如阿司匹林、吲哚美辛,可降低患结直肠癌及其他潜在恶性肿瘤的风险。
我们研究了非甾体抗炎药对滥用含阿司匹林、非那西丁、咖啡因或可待因的混合镇痛药者肿瘤患病率的影响。将1968年至1983年间接受尸检的618名镇痛药滥用者与一个无镇痛药滥用证据、在性别、年龄和尸检年份方面匹配的对照组进行比较。
与对照组相比,发现滥用者患恶性肿瘤的总体风险为对照组的0.40倍。排除镇痛药滥用者中尿路肿瘤增加的患者后,风险进一步降至0.28。未发现非甾体抗炎药对前列腺癌患者有统计学显著影响。这些结果鼓励对高危患者进行前瞻性对照研究。